-

CVC Credit Prices Third New CLO Of 2022

Apidos XL(40) is the latest CLO priced by CVC’s $25 billion Performing Credit platform

NEW YORK--(BUSINESS WIRE)--CVC Credit is pleased to announce that it has priced Apidos XL (40), a Collateralized Loan Obligation (“CLO”) fund totalling $500 million, arranged by Goldman Sachs. This is the third new issue CLO priced by CVC Credit’s transatlantic performing credit business has priced this year, following the pricing of Apidos XXXIX and Cordatus XXIII in February and March respectively.

Apidos XL will increase CVC Credit’s global AUM to over $34 billion (€32 billion). The transaction has been structured with a five-year reinvestment period and was very well-supported by both existing and new investors. As with previous Apidos funds, Apidos XL is primarily comprised of broadly syndicated First Lien Senior Secured Loans and was approximately 90% purchased at pricing.

Kevin O’Meara, Partner, Portfolio Manager and Head of the US Performing Credit Business at CVC Credit, said: “We are delighted to have priced CVC Credit’s second US CLO of 2022 with the collective expertise of our investment, structuring and operations teams, and having done so despite such volatile market conditions is a real achievement.”

Gretchen Bergstresser, Partner and Global Head of Performing Credit at CVC Credit, commented: “This pricing is testament to the combined strengths of our terrific teams in New York and London and we are thrilled with the continued strong support we receive from our wide base of investors. In spite of tough market conditions we expect to continue to launch new issuances across our transatlantic CLO business through the rest of the year, with the next one expected to be in Europe in the next month.”

About CVC Credit

CVC Credit is the credit management business of CVC. CVC Credit is a global credit asset manager with offices in the U.S. and Europe, more than 60 investment professionals and €32 billion assets under management. The platform seeks to generate for its investors positive absolute returns and attractive risk-adjusted returns on capital throughout the credit cycle. CVC Credit has built a diverse business which creates significant synergies across its investment strategies. For further information about CVC Credit please visit: www.cvc.com/credit. Follow us on LinkedIn.

Contacts

For CVC Credit Partners
Nick Board
Director, Communications
+44 (0) 20 7420 4200
nboard@cvc.com

CVC Credit


Release Versions

Contacts

For CVC Credit Partners
Nick Board
Director, Communications
+44 (0) 20 7420 4200
nboard@cvc.com

More News From CVC Credit

CVC Credit prices three CLO transactions in a week

NEW YORK--(BUSINESS WIRE)--CVC Credit, the $46 billion global credit management business of CVC, is pleased to announce the successful pricing of Apidos LII, a new $400 million (c.€380 million) Collateralized Loan Obligation ("CLO"), along with the reset of Apidos XLII, which now totals approximately $550 million (c.€525 million). These two transactions, plus the recently announced pricing of Cordatus XXXIV in Europe, mark a strong start to 2025 for CVC Credit’s Performing Credit platform, brin...

CVC Completes Acquisition of Therakos from Mallinckrodt

NEW YORK & RARITAN, N.J. & DUBLIN--(BUSINESS WIRE)--CVC, a leading global private markets manager, today completed the previously announced acquisition of the Therakos business from Mallinckrodt plc (“Mallinckrodt”), a global specialty pharmaceutical company. The investment in Therakos from CVC Capital Partners Fund IX will provide the resources and expertise to further develop the business and its services which improve the lives of patients. Therakos is the leading company in Extracorporeal P...

CVC Credit prices tenth new issue CLO of the year with $500m Apidos L (50)

NEW YORK--(BUSINESS WIRE)--CVC Credit, the $45bn global credit management business of CVC, is pleased to announce that it has successfully priced Apidos L (50), a new $500m (c.€460m) Collateralized Loan Obligation ("CLO"). Apidos L (50) is CVC Credit’s tenth new issue CLO pricing globally this year. Apidos L (50) has a five-year reinvestment period and two-year non-call period that is supported by an actively managed, diversified portfolio of senior secured loans and bonds. The portfolio was mo...
Back to Newsroom